SARS-CoV-2 and Innate Immunity: the Good, the Bad, and the "goldilocks"

Overview

Journal Cell Mol Immunol

Date 2023 Nov 21

PMID 37985854

Authors

Benjamin L Sievers

Mark T K Cheng

Kata Csiba

Bo Meng

Ravindra K Gupta

Affiliations

Soon will be listed here.

Abstract

An ancient conflict between hosts and pathogens has driven the innate and adaptive arms of immunity. Knowledge about this interplay can not only help us identify biological mechanisms but also reveal pathogen vulnerabilities that can be leveraged therapeutically. The humoral response to SARS-CoV-2 infection has been the focus of intense research, and the role of the innate immune system has received significantly less attention. Here, we review current knowledge of the innate immune response to SARS-CoV-2 infection and the various means SARS-CoV-2 employs to evade innate defense systems. We also consider the role of innate immunity in SARS-CoV-2 vaccines and in the phenomenon of long COVID.

Citing Articles

Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability.

Mai K, Pan W, Lin Z, Wang Y, Yang Z Adv Biotechnol (Singap). 2025; 3(1):5.

PMID: 39883362 DOI: 10.1007/s44307-025-00057-9.

Comparative Analysis of Virology and Pathogenesis of SARS-CoV-2 and HIV Infections: Implications for Public Health and Treatment Strategies.

Olebo D, Igwe M Infect Drug Resist. 2025; 18():269-283.

PMID: 39835166 PMC: 11742764. DOI: 10.2147/IDR.S498430.

Immune Response Against SARS-CoV-2.

Stufano A, Schino V, Lucchese G Vaccines (Basel). 2025; 12(12.

PMID: 39772051 PMC: 11680432. DOI: 10.3390/vaccines12121390.

COVID-19-sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland.

Kosiorek P, Mikoluc B, Stroz S, Hryniewicz A, Kazberuk D, Milewski R Cancer Immunol Immunother. 2024; 74(1):27.

PMID: 39708120 PMC: 11663207. DOI: 10.1007/s00262-024-03895-z.

The role of inflammatory gene polymorphisms in severe COVID-19: a review.

Yip J, Oo A, Ng Y, Chin K, Tan K, Chu J Virol J. 2024; 21(1):327.

PMID: 39707400 PMC: 11662554. DOI: 10.1186/s12985-024-02597-3.

References

Kee J, Thudium S, Renner D, Glastad K, Palozola K, Zhang Z . SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature. 2022; 610(7931):381-388. PMC: 9533993. DOI: 10.1038/s41586-022-05282-z. View

Zhang J, Wu H, Yao X, Zhang D, Zhou Y, Fu B . Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm. Cell Mol Immunol. 2021; 18(5):1305-1307. PMC: 7976727. DOI: 10.1038/s41423-021-00665-0. View

McMenamin M, Nealon J, Lin Y, Wong J, Cheung J, Lau E . Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis. 2022; 22(10):1435-1443. PMC: 9286709. DOI: 10.1016/S1473-3099(22)00345-0. View

Neches R, Kyrpides N, Ouzounis C . Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion. mBio. 2021; 12(1). PMC: 7845636. DOI: 10.1128/mBio.03014-20. View

Mesner D, Reuschl A, Whelan M, Bronzovich T, Haider T, Thorne L . SARS-CoV-2 evolution influences GBP and IFITM sensitivity. Proc Natl Acad Sci U S A. 2023; 120(5):e2212577120. PMC: 9945951. DOI: 10.1073/pnas.2212577120. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Santer D, Li D, Ghosheh Y, Zahoor M, Prajapati D, Hansen B . Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity. Nat Commun. 2022; 13(1):6992. PMC: 9667439. DOI: 10.1038/s41467-022-34709-4. View

Thorne L, Bouhaddou M, Reuschl A, Zuliani-Alvarez L, Polacco B, Pelin A . Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2021; 602(7897):487-495. PMC: 8850198. DOI: 10.1038/s41586-021-04352-y. View

Madiraju C, Novack J, Reed J, Matsuzawa S . K63 ubiquitination in immune signaling. Trends Immunol. 2022; 43(2):148-162. PMC: 8755460. DOI: 10.1016/j.it.2021.12.005. View

10.

Collier D, Ferreira I, Kotagiri P, Datir R, Lim E, Touizer E . Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021; 596(7872):417-422. PMC: 8373615. DOI: 10.1038/s41586-021-03739-1. View

11.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

12.

Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L . Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine. 2020; 61:103104. PMC: 7677597. DOI: 10.1016/j.ebiom.2020.103104. View

13.

Ferreira I, Lee C, Foster W, Abdullahi A, Dratva L, Tuong Z . Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly. Cell Rep. 2023; 42(8):112991. DOI: 10.1016/j.celrep.2023.112991. View

14.

Muth D, Corman V, Roth H, Binger T, Dijkman R, Gottula L . Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci Rep. 2018; 8(1):15177. PMC: 6181990. DOI: 10.1038/s41598-018-33487-8. View

15.

Zhao X, Sehgal M, Hou Z, Cheng J, Shu S, Wu S . Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses. J Virol. 2017; 92(6). PMC: 5827390. DOI: 10.1128/JVI.01535-17. View

16.

Roberts S, Lawrence M, Klimczak L, Grimm S, Fargo D, Stojanov P . An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013; 45(9):970-6. PMC: 3789062. DOI: 10.1038/ng.2702. View

17.

Azgari C, Kilinc Z, Turhan B, Circi D, Adebali O . The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense. Viruses. 2021; 13(3). PMC: 7999997. DOI: 10.3390/v13030394. View

18.

Taha T, Suryawanshi R, Chen I, Correy G, McCavitt-Malvido M, OLeary P . A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo. PLoS Pathog. 2023; 19(8):e1011614. PMC: 10499221. DOI: 10.1371/journal.ppat.1011614. View

19.

Peluso M, Lu S, Tang A, Durstenfeld M, Ho H, Goldberg S . Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021; 224(11):1839-1848. PMC: 8643408. DOI: 10.1093/infdis/jiab490. View

20.

Alhammad Y, Kashipathy M, Roy A, Gagne J, McDonald P, Gao P . The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase. J Virol. 2020; 95(3). PMC: 7925111. DOI: 10.1128/JVI.01969-20. View